Literature DB >> 19369654

Statin islands and PPAR ligands in platelets.

Richard P Phipps, Neil Blumberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19369654      PMCID： PMC2745197          DOI： 10.1161/ATVBAHA.109.184648

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  21 in total

1.  Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes?

Authors:  Jan Kristian Damås; Luca Puccetti; Pål Aukrust
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

Review 2.  Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?

Authors:  Philip J Barter; Kerry-Anne Rye
Journal:  Circulation       Date:  2006-03-28       Impact factor: 29.690

3.  Immunology. The root of platelet production.

Authors:  Amy E Geddis; Kenneth Kaushansky
Journal:  Science       Date:  2007-09-21       Impact factor: 47.728

4.  Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta.

Authors:  Ferhana Y Ali; Simon J Davidson; Leonardo A Moraes; Suzanne L Traves; Mark Paul-Clark; David Bishop-Bailey; Timothy D Warner; Jane A Mitchell
Journal:  FASEB J       Date:  2005-12-20       Impact factor: 5.191

5.  Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.

Authors:  Samina Yasmin Khan; Marguerite R Kelher; Joanna M Heal; Neil Blumberg; Lynn K Boshkov; Richard Phipps; Kelly F Gettings; Nathan J McLaughlin; Christopher C Silliman
Journal:  Blood       Date:  2006-06-13       Impact factor: 22.113

6.  Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.

Authors:  J Kaufman; S L Spinelli; E Schultz; N Blumberg; R P Phipps
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

Review 7.  Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.

Authors:  Bart Staels; Michel Maes; Alberto Zambon
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-07-15

Review 8.  Beyond hemostasis: the role of platelets in inflammation, malignancy and infection.

Authors:  Archibald McNicol; Sara J Israels
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2008-06

9.  Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.

Authors:  Denise M Ray; Sherry L Spinelli; Stephen J Pollock; Thomas I Murant; Jamie J O'Brien; Neil Blumberg; Charles W Francis; Mark B Taubman; Richard P Phipps
Journal:  Thromb Haemost       Date:  2008-01       Impact factor: 5.249

Review 10.  Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.

Authors:  Réjane Paumelle; Bart Staels
Journal:  Trends Cardiovasc Med       Date:  2008-04       Impact factor: 6.677
View more
  3 in total

1.  Omega-6 DPA and its 12-lipoxygenase-oxidized lipids regulate platelet reactivity in a nongenomic PPARα-dependent manner.

Authors:  Jennifer Yeung; Reheman Adili; Adriana Yamaguchi; Cody J Freedman; Angela Chen; Ryan Shami; Aditi Das; Theodore R Holman; Michael Holinstat
Journal:  Blood Adv       Date:  2020-09-22

2.  The many roles of statins in ischemic stroke.

Authors:  Jingru Zhao; Xiangjian Zhang; Lipeng Dong; Ya Wen; Lili Cui
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

Review 3.  Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.

Authors:  Alexios S Antonopoulos; Marios Margaritis; Regent Lee; Keith Channon; Charalambos Antoniades
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.